Pioneering Clinical Studies: Insights from Norway
Presented by SGInnovate and Innovation Norway
Norway has an already well-documented track record of quality clinical trials, with a specific strength in oncology, which is the branch of medicine that deals with the prevention, diagnosis, and treatment of cancer.
The Norwegian Ministry of Health has recently launched an ambitious strategic plan to further establish Norway as a country of excellence in this important field.
To reach this goal, Norway will offer one of the oldest and broadest collections of health registries in the world - health data, biobanks and a health analysis platform offering a unique tool to pharmaceutical companies – to create a single entry point to access all the country’s clinical trial resources. This will be in combination with a well-structured specialist care system and a population with a high willingness to partake in clinical trials.
Join us in our presentations by experts in the Norwegian Healthcare system, who will share about such clinical trial strategies of the future. From this session, we hope for Singapore HealthTech players to develop a better understanding of the innovation needs and strategies from Norway, as well as hear about the clinical studies directly from the experts themselves. This could be relevant for clinical and open collaborations for researchers and overseas markets.
Date: 21 April 2021, Wednesday
Time: 4:00pm – 5:00pm (Singapore Time/ UTC +8)
4:00pm – 4:05 pm: Opening Remarks by SzeKi Sim, Executive Director – Community & Brand, SGInnovate and Pål Kastmann, Director, Innovation Norway
4:05pm – 4:15pm: Presentation on ‘Clinical Study and Strategic Plan’ by Maiken Engelstad, Deputy Director General, Ministry of Health and Care Services
4:15pm – 4:25pm: Presentation on ‘Health Data Program and Health Analysis Platform’ by Marianne Braaten, Project Manager, Directorate of e-Health
4:25pm – 4:35pm: Presentation on ‘Technology Transfer for the South East Region’ by Siri Kolle, Clinical Vice President, Inven2
4:35pm – 5:00pm: Panel Discussion and Q&A with:
- Maiken Engelstad, Deputy Director General, Ministry of Health and Care Services
- Marianne Braaten, Project Manager, Directorate of e-Health
- Siri Kolle, Clinical Vice President, Inven2
- Hege Edvardsen, Senior Advisor R&D - Association of Pharmaceutical Industry, LMI
- Ketil Widerberg, CEO, Oslo Cancer Cluster
- Trine Radmann, Head of International Affairs, Norway Health Tech
- Moderator: Catherine Capdeville, Healthcare Lead, Innovation Norway
Maiken Engelstad, Deputy Director General, Ministry of Health and Care Services
Maiken Engelstad works at the Department of specialised healthcare services in the Ministry of Health and heads the Competence, Research and Innovation unit. She leads the recently presented first and ambitious National strategy on clinical trials (2021-2025). The government's goal is to ensure that clinical trials are a fully integrated part of the health care services provided to patients and double the number of trials by 2025.
Maiken holds a BSc in Biochemistry from the Imperial College of London, a PhD in molecular virology from the University of Oxford and a Master from Harvard School of Public Health.
Marianne Braaten, Project Manager, Directorate of eHealth
Marianne Braaten works in the Directorate for e-Health, where she is the Program Manager for the Health Data program. Marianne has extensive experience in leading major projects for the Health Ministry, Directorate for e-Health and the University of Oslo. In the Health Data program, she established the Health Analysis Platform and Health Data Service, making it easier to access health data for research and clinical trials.
Siri Kolle, Clinical Vice President, Inven2
Siri Kolle works as the Clinical Vice President of Inven2, the Technology Transfer entity for the hospitals in the South East Region of Norway and the University Hospital of North Norway, covering more than 60% of the Norwegian population. Siri has long experience within clinical trials, both as a clinical research manager in pharmaceutical companies and at Inven2. The clinical team she is heading at Inven2 is responsible for managing all clinical trial agreements with the industry on behalf of the Hospitals, having more than 400 ongoing agreements for clinical trials in their portfolio. Her primary focus is on efficient processes and being a facilitator to make the hospitals attractive for industry collaboration. Siri has a Master’s degree from the Norwegian School of Sport Sciences.
Hege Edvardsen, Senior Advisor R&D - Association of Pharmaceutical Industry, LMI
Hege Edvardsen leads the work related to R&D at the trade association of the Pharmaceutical Industry. Previous to that, Hege worked at Abbvie, where she was Head of Research and Operations Scandinavia.
In her role, she focuses on clinical studies, the implementation of personalized medicines and the continuation of the INSPIRE project, a public-private partnership between the Norwegian Cancer Registry, the Cancer Society and the Pharma industry. Hege is instrumental in building cooperation across institutions. Hege holds a PhD from the Faculty of Medicine at the University of Oslo and has a background as a cancer researcher from the Norwegian Radium Hospital.
Ketil Widerberg, CEO, Oslo Cancer Cluster
Ketil F. Widerberg builds on a long experience in realizing new projects within oncology in the biopharmaceutical company Photocure ASA in collaboration with academic institutions and international commercial partners.
Ketil has a broad operational experience ranging from explorative project management to being responsible for business development. Widerberg’s educational background spans from preclinical medical school to management studies. He also holds a MBA from the University of Cambridge.
Trine Radmann, Head of International Affairs, Norway Health Tech
Trine Radmann leads the international affairs department at Norway Health Tech. Previous to that, she worked at The Confederation of Norwegian Enterprise, NHO, where she headed the NHOs Brussels office. She had a political engagement in the former government of Prime Minister Kjell Magne Bondevik and was Head of Information and branding in Norway’s Yes-to-the-EU-campaign. Trine is instrumental in securing and building relationships nationally and internationally for Norwegian businesses. Trine holds a Bachelor of Science in Psychology and a Master in Political Science from the University of Georgia and the University of Oslo.
Catherine Capdeville, Healthcare Lead, Innovation Norway
Catherine Capdeville leads the Healthcare department at Innovation Norway, focusing on the Norwegian Healthtech and Biotechnology industry. She has a long leadership experience in the healthcare industry sector, mainly from the medical device and In-Vitro Diagnostic industries. She holds a healthcare degree from the IFSI Xavier Arnozan in France and a Business and Management degree from IESE Business School in Barcelona and New York.